| Jennifer Bolnick, MD | |
|
904 7th Ave, Seattle, WA 98104 | |
| (206) 860-5404 | |
| (206) 860-2295 |
| Full Name | Jennifer Bolnick |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 904 7th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073650693 | NPI | - | NPPES |
| 8133613 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | MD00027849 (Washington) | Secondary |
| 207Q00000X | Family Medicine | MD00027849 (Washington) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
A group of researchers at the Spanish National Cancer Research Centre have identified a protein called RanBP6 as a new regulator of EGFR. In a paper published in Nature Communications they show how silencing of RanBP6 promoted glioma growth, by upregulating EGFR expression.
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
Since the 2006 launch of USAID's Neglected Tropical Disease (NTD) Control Program, which is managed by RTI, "more than 447 million NTD treatments have been provided to more than 82 million people," the Global Network for Neglected Tropical Diseases' "End the Neglect" blog reports.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis (CF). The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Bolnick, MD Po Box 34584, Seattle, WA 98124-1584 Ph: (509) 241-7349 | Jennifer Bolnick, MD 904 7th Ave, Seattle, WA 98104 Ph: (206) 860-5404 |
News Archive
A group of researchers at the Spanish National Cancer Research Centre have identified a protein called RanBP6 as a new regulator of EGFR. In a paper published in Nature Communications they show how silencing of RanBP6 promoted glioma growth, by upregulating EGFR expression.
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
Since the 2006 launch of USAID's Neglected Tropical Disease (NTD) Control Program, which is managed by RTI, "more than 447 million NTD treatments have been provided to more than 82 million people," the Global Network for Neglected Tropical Diseases' "End the Neglect" blog reports.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis (CF). The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days.
› Verified 3 days ago
Claire M Barnett, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2001 E Madison St, Seattle, WA 98122 Phone: 206-328-7722 Fax: 206-720-4657 | |
Dr. Gregory Parada, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8720 14th Ave S, Seattle, WA 98108 Phone: 206-762-3730 Fax: 206-764-5494 | |
Michael S Grabinski, M.D., M.P.H. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 904 7th Ave, 8th Floor, Seattle, WA 98104 Phone: 206-860-4424 Fax: 206-720-7424 | |
Xin Jie Luo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Fauntleroy Way Sw, Seattle, WA 98116 Phone: 206-201-0551 Fax: 206-201-0552 | |
Brooke Elizabeth Parker, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11011 Meridian Ave N Ste 201, Seattle, WA 98133 Phone: 206-520-5000 | |
Eunice Mbela Nachinga, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 125 16th Ave E # Csb545, Seattle, WA 98112 Phone: 206-326-3769 | |
Michelle K Xu, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1401 Madison St Ste 100, Seattle, WA 98104 Phone: 206-386-6111 Fax: 206-386-6113 |